1. Home
  2. FATE vs PMF Comparison

FATE vs PMF Comparison

Compare FATE & PMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • PMF
  • Stock Information
  • Founded
  • FATE 2007
  • PMF 2001
  • Country
  • FATE United States
  • PMF United States
  • Employees
  • FATE N/A
  • PMF N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • PMF Finance/Investors Services
  • Sector
  • FATE Health Care
  • PMF Finance
  • Exchange
  • FATE Nasdaq
  • PMF Nasdaq
  • Market Cap
  • FATE 177.7M
  • PMF 209.2M
  • IPO Year
  • FATE 2013
  • PMF N/A
  • Fundamental
  • Price
  • FATE $1.14
  • PMF $7.86
  • Analyst Decision
  • FATE Hold
  • PMF
  • Analyst Count
  • FATE 7
  • PMF 0
  • Target Price
  • FATE $3.83
  • PMF N/A
  • AVG Volume (30 Days)
  • FATE 1.7M
  • PMF 61.3K
  • Earning Date
  • FATE 08-12-2025
  • PMF 01-01-0001
  • Dividend Yield
  • FATE N/A
  • PMF 5.36%
  • EPS Growth
  • FATE N/A
  • PMF N/A
  • EPS
  • FATE N/A
  • PMF N/A
  • Revenue
  • FATE $13,335,000.00
  • PMF N/A
  • Revenue This Year
  • FATE N/A
  • PMF N/A
  • Revenue Next Year
  • FATE N/A
  • PMF N/A
  • P/E Ratio
  • FATE N/A
  • PMF N/A
  • Revenue Growth
  • FATE 105.85
  • PMF N/A
  • 52 Week Low
  • FATE $0.66
  • PMF $7.69
  • 52 Week High
  • FATE $5.92
  • PMF $10.56
  • Technical
  • Relative Strength Index (RSI)
  • FATE 46.69
  • PMF 48.75
  • Support Level
  • FATE $1.05
  • PMF $7.92
  • Resistance Level
  • FATE $1.18
  • PMF $7.92
  • Average True Range (ATR)
  • FATE 0.08
  • PMF 0.07
  • MACD
  • FATE -0.00
  • PMF 0.01
  • Stochastic Oscillator
  • FATE 54.76
  • PMF 61.28

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About PMF PIMCO Municipal Income Fund

PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.

Share on Social Networks: